ArticleHealth science reports2026
Silent Risks in the Blood Supply: Co-Inherited Glucose-6-Phosphate Dehydrogenase Deficiency and Sickle Cell Trait Among Donors at the Cape Coast Teaching Hospital, Ghana: A Cross-Sectional Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Blood transfusion saves lives, but red cell enzymopathies and hemoglobin variants can reduce red cell survival under oxidative stress. In sub-Saharan Africa, blood donors are not routinely screened for glucose-6-phosphate dehydrogenase (G6PD) deficiency or sickle cell trait (SCT). Evidence on co-inheritance in donors is limited, despite possible harm to vulnerable recipients such as neonates and chronically transfused patients. This study determined the prevalence of G6PD deficiency, SCT, and their co-inheritance among blood donors, and assessed donor awareness and selected laboratory findings relevant to transfusion safety. Methods: A hospital-based cross-sectional study was conducted between February and August 2023 among 250 blood donors aged 16-50 years selected through simple random sampling. Following informed consent, participants completed a structured questionnaire. G6PD status was determined using the methemoglobin reduction test, while sickling was screened using sodium metabisulfite. Hemoglobin electrophoresis was used to determine hemoglobin phenotype, and Full Blood Count (FBC) analysis was performed using the Sysmex XN-350 hematology analyzer. Data were analyzed using SPSS version 26.0, with Results: The mean age was 21.8 ± 6.3 years. Most donors were males [146/250 (58.4%)], students [184/250 (73.6%)], and first-time donors (174/250, 69.6%). Most donors did not know their G6PD status (246/250, 98.4%), blood group (167/250, 66.8%), or sickling status (235/250, 94%). Laboratory testing showed 35/250, 14% had full G6PD deficiency, 55/250, 22% had sickle cell trait (predominantly Hb AS), and 15/250, 6% co-inherited both conditions. Blood group O Rh "D" positive was the most common (143/250, 57.2%). G6PD status and full blood count parameters differed by sex ( Conclusion: The 6% co-inheritance of G6PD deficiency and SCT among blood donors, together with low donor awareness, highlights potential transfusion safety concerns. Targeted donor education, pre-donation counseling, and screening policies may improve transfusion safety in high-prevalence settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.